✦ LIBER ✦

Targeted Imaging of Colorectal Dysplasia in Living Mice With a Confocal Microendoscope

✍ Scribed by Elahi, Sakib F. ;Miller, Sharon J. ;Wang, Thomas D.

Book ID: 122125057
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 260 KB
Volume: 140
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(11)63168-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeted imaging of colorectal dysplasia

Targeted imaging of colorectal dysplasia in living mice with fluorescence microendoscopy

✍ Wang, Thomas D.; Elahi, Sakib F.; Miller, Sharon J.; Joshi, Bishnu 📂 Article 📅 2011 🏛 The Optical Society 🌐 English ⚖ 923 KB

Longitudinal Molecular Imaging with Sing

Longitudinal Molecular Imaging with Single Cell Resolution of Disseminated Ovarian Cancer in Mice with a LED-based Confocal Microendoscope

✍ Sakib F. Elahi; Zhongyao Liu; Kathryn E. Luker; Richard S. Kwon; Gary D. Luker; 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 304 KB

Counting Nucleosomes in Living Cells wit

Counting Nucleosomes in Living Cells with a Combination of Fluorescence Correlation Spectroscopy and Confocal Imaging

✍ Thomas Weidemann; Malte Wachsmuth; Tobias A. Knoch; Gabriele Müller; Waldemar Wa 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 734 KB

In vivo imaging of colorectal cancer gro

In vivo imaging of colorectal cancer growth and metastasis by targeting MACC1 with shRNA in xenografted mice

✍ Pichorner, Andreas; Sack, Ulrike; Kobelt, Dennis; Kelch, Inken; Arlt, Franziska; 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 602 KB

PET imaging of tumor angiogenesis in mic

PET imaging of tumor angiogenesis in mice with VEGF-A–targeted 86Y-CHX-A″-DTPA-bevacizumab

✍ Tapan K. Nayak; Kayhan Garmestani; Kwamena E. Baidoo; Diane E. Milenic; Martin W 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 407 KB

## Abstract Bevacizumab is a humanized monoclonal antibody that binds to tumor‐secreted vascular endothelial growth factor (VEGF)‐A and inhibits tumor angiogenesis. In 2004, the antibody was approved by the US Food and Drug Administration (FDA) for the treatment of metastatic colorectal carcinoma i

Targeted disruption of Col11a2 produces

Targeted disruption of Col11a2 produces a mild cartilage phenotype in transgenic mice: Comparison with the human disorder otospondylomegaepiphyseal dysplasia (OSMED)

✍ Shi-Wu Li; Masamine Takanosu; Machiko Arita; Yunhua Bao; Zhao-Xia Ren; Alfred Ma 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 908 KB